Relationship between pharmacokinetic parameters and occurrence of adverse events in clinical trials performed in Europe and United States for an angiotensin II receptor antagonist, telmisartan.

Shinji Tatami, Akiko Sarashina, Norio Yamamura, Takashi Igarashi, Yusuke Tanigawara

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Relationship between pharmacokinetic parameters and occurrence of adverse events in clinical trials performed in Europe and United States for an angiotensin II receptor antagonist, telmisartan.'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences